Vaccinia Virus Strain New York City Board Of Health Live (attenuated) Antigen

Vaccinia Virus Strain New York City Board Of Health Live (attenuated) Antigen Uses, Dosage, Side Effects, Food Interaction and all others data.

The New York City Board of Health strain of Vaccinia is a viral strain used as a component of some smallpox vaccinations. ACAM2000, a percutaneously administered smallpox vaccine that was approved by the FDA in 2007, contains live antigens of this strain.

Trade Name Vaccinia Virus Strain New York City Board Of Health Live (attenuated) Antigen
Generic Smallpox (Vaccinia) Vaccine, Live
Smallpox (Vaccinia) Vaccine, Live Other Names Smallpox (vaccinia) vaccine, live, Smallpox vaccine, Vaccinia virus live antigen, B, Vaccinia virus strain new york city board of health live (attenuated) antigen, Vaccinia virus strain new york city board of health live antigen, Vaccininum, Vaccinotoxinum
Type
Groups Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Vaccinia Virus Strain New York City Board Of Health Live (attenuated) Antigen
Vaccinia Virus Strain New York City Board Of Health Live (attenuated) Antigen

Uses

The live antigen of the New York City Board of Health strain of Vaccinia is indicated (within the ACAM2000 formulation) for active immunization against smallpox disease in patients determined to be at high risk of contracting smallpox infection.

Vaccinia Virus Strain New York City Board Of Health Live (attenuated) Antigen is also used to associated treatment for these conditions: Smallpox

Food Interaction

No interactions found.

Innovators Monograph

You find simplified version here Vaccinia Virus Strain New York City Board Of Health Live (attenuated) Antigen

*** Taking medicines without doctor's advice can cause long-term problems.
Share